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"Diabetes 2000" will parallel a major diabetic retinopathy 
public information campaign recently announced by the 
National Eye Institute. The NE/' s National Eye Health 
Education Program (NEHEP), which targets both diabetic 
retinopathy and glaucoma, is fashioned along the lines of ear-
lier federal initiatives against smoking and high blood pres-
sure. By continuously updating our medical knowledge and 
skills related to this multisystem disorder, and by forging 
partnerships between physicians in the effective and efficient 
management of diabetic patients, we have a unique and 
important opportunity - we can reduce preventable blindness 
from diabetes by the year 2000. 
In no field of medicine is continuing medical education of 
physicians more critical than in the management of diabetes. 
Twelve million Americans have diabetes mellitus, and the dis-
ease knows no medical specialty boundaries. In addition to 
being a major cause of morbidity from multisystem complica-
tions, such as renal failure, neuropathy, and cardiovascular 
disease; diabetes is the leading cause of blindness among 
working-age Americans. It accounts for at least 12% of new 
cases of blindness every year in the United States. Diabetic 
retinopathy is often asymptomatic at its most treatable stage, 
emphasizing the importance of early diagnosis of this retinal 
complication. New information about diabetes emerges almost 
monthly as published in some specialty journal, making it 
mandatory to find better ways to "keep up" with advances in 
this field-the stakes are simply too high to do otherwise. 
In response to the increasing importance of the overall 
problem of diabetes and diabetic retinopathy, and the avail-
ability of improved treatment regimens defined by published 
clinical trial results, the American Academy of Ophthalmol-
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ogy (AAO) has embarked on a long-term education project 
designed to more rapidly translate research findings to medi-
cal benefits for the American public. The new project-
"Elimination of Preventable Blindness from Diabetes by the 
Year 2000"-or "Diabetes 2000"-was announced at the 
AAO's 1989 Annual Meeting. 
Facts about diabetic retinopathy 
The majority of diabetic patients have non-insulin-depen-
dent diabetes mellitus (NIDDM, Type II). Usually diagnosed 
after age 40, Type II diabetic patients may or may not be treat-
ed with insulin. Much fewer patients have insulin-dependent 
diabetes mellitus (IDDM, Type I), which is usually diagnosed 
before age 30. Type I diabetics experience more frequent and 
severe ocular complications than do Type II diabetics. After 5 
years, 23% of Type I diabetic patients have retinopathy; after 
10 years, almost 60% have retinopathy; and after 15 years, 
80% have it. Proliferative diabetic retinopathy (PDR)-the 
most threatening form of retinopathy-is present in 25% of 
Type I patients after 15 years and often remains asymptomatic 
well beyond the optimal stage for treatment. 
An estimated 700,000 Americans have proliferative diabet-
ic retinopathy and 500,000 have macular edema. The annual 
projected incidence of new cases of PDR and macular edema 
is 65,000 and 75,000, respectively. About 8,000 new cases of 
blindness a year in the United States are caused by complica-
tions of diabetes. 
What can be done 
"Diabetes 2000" provides the means to close the gap 
between advances in research and changes in treatment pat-
terns. While most physicians are aware of diabetic retinopa-
thy, the AAO's goal now is to focus attention on the impor-
tance of early diagnosis and timely treatment of diabetic 
retinopathy based on the important advances of the last 5 to 10 
years. For example, we now know that timely laser photoco-
agulation surgery can reduce the risk of visual loss from pro-
liferative diabetic retinopathy by at least 50%. We know that 
timely laser photocoagulation surgery of diabetic macular 
edema can reduce the risk of moderate visual loss by 50%. We 
know that vitrectomy surgery can restore useful vision to 
some diabetic patients who have advanced diabetic retinopa-
thy. 
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The need for 
effective partnerships 
As the working title implies, "Diabetes 2000" will be a 
long-term project aimed at a specific disease: Diabetic retino-
pathy and its complications. Several phases are anticipated. 
Providing the latest research findings to ophthalmologists 
and other physicians who care for those patients is the first 
priority, followed by patient and public information. Initially, 
new advances and treatment guidelines for the medical and 
surgical treatment of diabetic eye disease will be emphasized 
through continuing education of ophthalmologists, other 
physicians, allied health professionals, residents, medical stu-
dents and specialists in diabetes-related education. 
In later phases, educational programs for diabetic patients 
and the public will be developed. Ultimately, improved eye 
care of diabetic patients is to be expected as a result of closer 
collaboration between the physician primarily responsible for 
the care of the patient's systemic illness, the patient and the 
ophthalmologist. Since diabetic patients can be asymptomatic 
despite significant progression of diabetic retinopathy, the 
importance of a renewed and improved partnership between 
the ophthalmologist and the patient's primary physician is 
critical. 
Because of the ambitious goal and long time frame, many 
other medical organizations and public groups are involved in 
Diabetes 2000. Representatives from various medical special-
ties, government agencies, and other organizations devoted to 
problems of the diabetic patient have been invited to partici-
pate. Since diabetes is a complex, multisystem disease whose 
overall management is the responsibility of physicians other 
than ophthalmologists, "Diabetes 2000" will stress involve-
ment of other physicians and medical specialty organizations 
in planning and implementing the project. 
The importance of finding ways to develop effective part-
nerships between the patient's primary physician, the ophthal-
mologist and the patient in the management of diabetic eye 
disease is a major goal. Another important aspect of the pro-
ject is the identification and promotion of existing diabete& 
eye health programs around the country, such as the Centers 
for Disease Control (CDC) Diabetes Translation Project. The 
AAO will encourage ophthalmologists to participate in nation-
al, regional and local programs already in operation, as spon-
sored by such organizations as the American Diabetes 
Association, the Juvenile Diabetes Foundation, Lions Clubs, 
and others. 
And in Hawaii 
Hawaii ophthalmologists are participating. Educational 
materials are being developed and demonstration projects are 
underway in some states to encourage ophthalmologists and 
other physicians to participate in continuing education pro-
grams concerned with the overall management of diabetic 
retinopathy. A Preferred Practice Pattern on diabetic retinopa-
thy is available through the offices of the American Academy 
of Ophthalmology (415-561-8500). This document provides 
the latest information concerning the management of diabetic 
retinopathy. The Hawaii Ophthalmological Society is actively 
involved in this national initiative and ophthalmologists in 
Hawaii are eager to help develop the necessary educational 
and service programs that will achieve this goal. 
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5 words per line. Payment must accompany order. 
EMPLOYMENT OPPORTUNITY 
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Physician Placement Hawaii has openings for 
physicians & other medical professionals all 
across the U.S. Mainland as well as here in 
Hawaii. We also have candidates interested in a 
Hawaii position. Call Earl Pajari at 395·7099. 
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AINA HAINA PROFESSIONAL BUILDING 
1p64 sf turnkey previous medical ole. & 837 
ST ole. space available. Lots of parking. 
GREAT LOCATION 
Carolyn Schnack Darrow (RA) 373·964 
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MAUl 
MAUl CLINIC BUILDING 
* 728 Sq. Ft. Office 
* X-Ray and Lab on Site 
* Renovation Allowances 
* Rental Allowance during Renovation 
* Ample Parking 
* 14 other Quality Medical Tenants in Bldg. 
OPM Call John Sullivan 
OIHANA PROPERTY MANAGEMENT 244-7684 
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MANOA 
Best street. 4 bd., 3 ba. Divorce forces sale. 
Gaylyn Li-Ma 530-1266 (pager) 946-0646 
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WAIMANALO, OAHU 
BEACH FRONT 
Beautiful beach home on magnificent white sand 
beach. Sleeps 8, $1500/week, Barbara, 733 
Bishop, Ste.1800, HNL, Hl96813; 808·531-1411 
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Let MEDPRO show you how! 
We come with 10 years of experience in fil· 
ing all types of medical claims. For a free 
consultation, please call 681-4434 and ask 
for Claudia Tateishi. 
LOCUM TENENS PROVIDED 
Internal Medicine and Family Practice avail-
able. Please contact Acute Care Medical 
Services. 262·4181. 
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Family Practice, Pediatrics, Urgent Care. 
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Waipahu. Equipment available. 
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Phone 671-3931 
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